drugset
drugset / Press release

DARZALEX® (daratumumab) Approved by U.S. FDA in Combination with Two Standard of Care Regimens for the Treatment of Patients with Multiple Myeloma Who Have Received At Least One Prior Therapy

2016-11-21 · Janssen Research & Development, LLC · original jnj.com ↗

Daratumumab · regulatory

NEWS RELEASE DARZALEX® (daratumumab) Approved by U.S. FDA in Combination with Two Standard of Care Regimens for the Treatment of Patients with Multiple Myeloma Who Have Received At Least One Prior Therapy 11/21/2016 1

The release as fetched from its publisher. jnj.com ↗